AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Challenges in Classifying Myelodysplastic Syndromes (MDS)
The chapter discusses the implications of having two different classification systems for MDS and how it affects clinical care and research. It highlights the importance of a unique and biologically based classification for diagnosing and treating patients with MDS. The challenges in developing drugs for MDS and integrating molecular data with morphologic diagnoses are also addressed.